TScan Therapeutics, Inc.TCRXNASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank0
Studio
Year-over-Year Change

Return on equity

Percentile
P0
Near historical low
vs 5Y Ago
-1.7x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025-105.40%-99.2%
2024-52.91%+10.5%
2023-59.14%+11.2%
2022-66.60%-120.2%
2021-30.24%-149.2%
202061.53%+291.7%
2019-32.10%-